Ipamorelin
5mg
Ipamorelin is a selective growth hormone secretagogue that has attracted research interest for its effects on growth hormone release and endocrine signalling pathways. Supplied as a high-purity lyophilised peptide for laboratory research purposes only.
$97.00
Add to wishlist Add to compareAsk about productDescription
Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue (GHS) family. It has been extensively studied for its selective activation of the growth hormone secretagogue receptor (GHS-R1a), stimulating endogenous growth hormone release while exhibiting greater receptor selectivity than earlier generations of growth hormone-releasing peptides.
Researchers have investigated Ipamorelin in preclinical and clinical settings to better understand growth hormone regulation, insulin-like growth factor-1 (IGF-1) signalling, endocrine physiology, and metabolic function. Due to its selective mechanism of action, Ipamorelin has become a widely studied research peptide in investigations involving muscle physiology, recovery, body composition, and healthy ageing.
Areas of Scientific Interest
- Research has investigated Ipamorelin for its selective stimulation of endogenous growth hormone release through activation of growth hormone secretagogue receptors.
- Clinical studies have examined its effects on circulating growth hormone and IGF-1 levels as part of research into endocrine physiology.
- Experimental research has explored Ipamorelin in studies involving metabolism, body composition, muscle physiology, recovery, and age-related biological processes.
- Researchers continue to investigate the role of selective growth hormone secretagogues in understanding hormonal regulation and growth hormone signalling pathways.
Product Features
- High-purity lyophilised peptide
- Contains 5mg Ipamorelin
- Manufactured for laboratory and scientific research
- Quality tested for identity and purity
- Securely packaged to help maintain product integrity
References
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.
- Smith RG, Van der Ploeg LHT, Howard AD, et al. Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews.
- Ghigo E, Arvat E, Broglio F, et al. Growth hormone secretagogues: physiological and clinical perspectives. European Journal of Endocrinology.
Reviews
There are no reviews yet.